medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (3)

First report of congenital tufting enteropathy in Cuba

Morales FA, Charles JRA, Peña PO, de Armas RY

Language: Spanish
References: 19
Page: 1-12
PDF size: 632.65 Kb.


ABSTRACT

Introduction: Tufting enteropathy, also known as intestinal epithelial dysplasia, is a very infrequent congenital disorder presenting as refractory diarrhea in infants.
Objective: Describe the first report of congenital tufting enteropathy in Cuba.
Case presentation: A presentation is provided of the first case of the disease in Cuba based on histopathological findings and accompanied by a description of the clinical, diagnostic and therapeutic aspects addressed.
Conclusions: Tufted enteropathy poses a diagnostic challenge as it does not exhibit a pathognomonic clinical courtship. The concomitance of chronic diarrhea with malformation disorders should set off alarms and guide clinical thinking and diagnostic methodology towards possible genetic disorders.


REFERENCES

  1. Changzhou C, Chen Y, Chen X, Ji F. Tufting Enteropathy: A Review of Clinical and Histological Presentation, Etiology, Management, and Outcome. Gastroenterol Res Pract. 2020;2020:5608069. DOI: 10.1155/2020/5608069

  2. Das B, Sivagnanam M. Congenital Tufting Enteropathy: Biology, Pathogenesis and Mechanisms. J Clin Med. 2020;10(1):19. DOI: 10.3390/jcm10010019

  3. Kawaguchi M, Yamamoto K, Takeda N, Fukushima T, Yamashita F, Sato K, et al. Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine. Commun Biol. 2019;2:11. DOI: 10.1038/s42003-018-0255-8

  4. Hassan K, Sher G, Hamid E, Hazima KA, Abdelrahman H, Mudahka FA, et al. Outcome associated with EPCAM founder mutation c.499dup in Qatar Eur J Med Genet. 2020;63(10):104023. DOI: 10.1016/j.ejmg.2020.104023

  5. Haas K, Martin B, Martín M, Kerner J. Intractable diarrhea in two brothers: late diagnosis of tufting enteropathy in adolescence. Dig Dis Sci. 2016;61(2):381-3.

  6. Hirabayashi KE, Moore AT, Mendelsohn BA, Taft RJ, Chawla A, Perry D, et al. Congenital sodium diarrhea and chorioretinal coloboma with optic disc coloboma in a patient with biallelic SPINT2 mutations, including p.(Tyr163Cys). Am J Med Genet A. 2018;176(4):997-1000. DOI: 10.1002/ajmg.a.38637

  7. Goulet O, Salomon J, Ruemmele F, de Serres NPM, Brousse N. Intestinal epithelial dysplasia (tufting enteropathy). Orphanet J Rare Dis. 2007;2:20. DOI: 10.1186/1750-1172-2-20

  8. Tang W, Huang T, Xu Z, Huang Y. Novel mutations in EPCAM cause congenital tufting enteropathy. J Clin Gastroenterol. 2018;52(1):1-6. DOI: 10.1097/MCG.0000000000000739

  9. Overeem AW, Posovszky C, Rings EHMM, Giepmans BNG, van IJzendoorn SCD. The role of enterocyte defects in the pathogenesis of congenital diarrheal disorders Dis Model Mech. 2016;9(1):1-12. DOI 10.1242/dmm.022269

  10. Martin BA, Kerner JA, Hazard FK, Longacre TA. Evaluation of intestinal biopsies for pediatric enteropathy: a proposed immunohistochemical panel approach. Am J Surg Pathol. 2014;38(10):1387-95. DOI: 10.1097/PAS.0000000000000314

  11. Ashworth I, Wilson A, Aquilina S, Parascandalo R, Mercieca V, Gerada J, et al. Reversal of Intestinal Failure in Children With Tufting Enteropathy Supported With Parenteral Nutrition at Home. J Pediatr Gastroenterol Nutr. 2018;66(6):967-71. DOI: 10.1097/MPG.0000000000001894

  12. Tan QK, Cardona DM, Rehder CW, McDonald MT. Identification of EPCAM mutation: clinical use of microarray. Clin Case Rep. 2017;5(6):980-5. DOI: 10.1002/ccr3.914

  13. AlMahamed S, Hammo A. New mutations of EpCAM gene for tufting enteropathy in Saudi Arabia. Saudi J Gastroenterol. 2017;23(2):123-6. DOI: 10.4103/1319-3767.203359

  14. Mashhadi SMY, Kazemimanesh M, Arashkia A, Azadmanesh K, Meshkat Z, Golichenari B, et al. Shedding light on the EpCAM: An overview. J Cell Physiol. 2019;234(8):12569-80. DOI: 10.1002/jcp.28132

  15. Huang L, Yang Y, Yang F, Liu S, Zhu Z, Lei Z, et al. Functions of EpCAM in physiological processes and diseases (Review). Int J Mol Med. 2018;42(4):1771-85. DOI: 10.3892/ijmm.2018.3764

  16. Zhou YQ, Wu GS, Kong YM, Zhang XY, Wang CL. New mutation in EPCAM for congenital tufting enteropathy: A case report World J Clin Cases. 2020;8(20):4975-80. DOI: 10.12998/wjcc.v8.i20.4975

  17. Pathak SJ, Mueller JL, Okamoto K, Das B, Hertecant J, Greenhalgh L, et al. EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome. Hum. Mutat. 2019;40(2):142-61. DOI: 10.1002/humu.23688

  18. Nakato G, Morimura S, Lu M, Feng X, Wu C, Udey MC. Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells Cells. 2020;9(8):1847. DOI: 10.3390/cells9081847

  19. Holt-Danborg L, Vodopiutz J, Nonboe AW, De Laffolie J, Skovbjerg S, Wolters VM, et al. SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase. Hum Mol Genet. 2019;28(5):828-41. DOI: 10.1093/hmg/ddy394




2020     |     www.medigraphic.com